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Background: There is a general agreement that one way to assess medical scientific progress in different 
countries is to analyse the publication rate in scientific journals and the nature of the limitations in facilities in 
such studies. 
Method: The status of paediatric practice and research in Nigeria in the last one decade with particular reference 
to the country’s progress in medical genetics was assessed, by auditing of published Nigerian studies in 
paediatrics between 1992 and 2001 based on articles published in 8 Nigerian medical journals and contributions 
made by Nigerian authors in two widely circulated international quarterly journals on tropical paediatrics. 
Results: Of the 2497 articles published in 8 Nigerian medical journals, 873(35%) articles were devoted to 
paediatrics. Of these, 270(31%) papers were related to genetics, dysmorphology and congenital malformations. 
There were also 101(11.6%) of the 873 articles that were primarily on non-genetic disorders, but needing 
investigatory facilities based on cytogenetic analysis, special staining techniques, molecular testing, special 
biochemistry or electron microscopy. Thus, there were 371(42.5%) of 873 studies devoted to paediatrics in 
which such special investigatory facilities could have improved the quality of practice or research in Nigeria. 
Regrettably, in only 8(2.2%) of 371 studies were the appropriate investigations available, mostly done either 
abroad or in collaboration with workers abroad. Furthermore, of the 1040 articles published in the last one 
decade in two widely circulated international quarterly journals on tropical paediatrics, up to 281(27%) were 
contributed by Nigerian authors. Of these 35(12.5%) were devoted to genetics and congenital malformations on 
Nigerian children, but in only 7 of these studies were all the necessary investigations available, but done in 
developed nations. 
Conclusion: This audit reveals that although Nigerian paediatricians have been very active in research, 
qualitative work on medical genetics is problematic and scientific progress in this very important field is very 
slow. It seems that in a developing nation like Nigeria collaboration with developed nations provides a strategy 
to address the problem. A plea is therefore made for the establishment of a reference medical genetics research 
center for Nigeria through such collaboration. 
 





The disciplines of population genetics, biochemical 
(or molecular) genetics and cytogenetics have recently 
reached an advanced state and are used in 
combination in studying, defining, counseling and 
treating inherited pathological processes. Medical 
genetics is currently regarded as an essential 
discipline for an understanding of human biology and 
has increasing relevance to clinical experience. 1 – 10 
A new era in cytogenetics began in 1956 with the 
discovery by Tjio and Levan1 that the human 
chromosome number was 46. Since then, the field of 
cytogenetics has advanced with explosive rapidity.
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Improved techniques using Giemsa banding and 
fluorescent staining became available in the 1970’s 
and these made possible the identification of 
individual chromosomes and their subsets. 1 – 3 
Abnormalities in chromosome number or structure 
associated with numerous clinical syndromes began to 
be diagnosed more than 40 years ago. 4 More 
sophisticated methods of detecting chromosomal 
aberrations became available in the late 1980’s. 5 
Detection of chromosomal aberrations in the human 
interphase nucleus by visualization of specific target 
DNA with radioactive and non-radioactive insitu 
techniques were developed in 1986 and were used to 
diagnose trisomy 18 with probe (L1.84). 5 
Translocations, deletions and inversions of 
chromosomes can now be precisely confirmed and 
related to abnormal phenotypes. 2 
 Applied research in paediatrics is now being 
organized in the light of new acquisitions of basic 
knowledge. Hereditary diseases are being precisely 
described with the localization and cloning of mutant 
genes and the identification of structural and 
functional proteins on which they depend. 2, 6 This is 
complimented by chemistry of recombinant DNA. 
Recombinant DNA technology has since the 1980’s7 
made possible the synthesis of protein products on 
mass scale-with production of safer vaccines, 8 safer 
and more culturally acceptable insulin, and antenatal 
diagnosis of a variety of conditions, including sickle 
cell disease. 9 
Recent advances in molecular genetics have made 
gene therapy possible. 10, 11 Gene therapy – which is 
the transfer of recombinant DNA, transiently or 
permanently into human cells for correction of disease 
2 began in September 1990. 10 A 4 years old girl with 
adenosine deaminase deficiency (ADA) was treated 
with autologous lymphocytes in which the normal 
ADA gene has been transfected. 10 Since, then, human 
gene therapy, as Miller11 asserts, has come of age. 
Human gene therapy clinical trials in malignant and 
non-malignant diseases – using the strategy of 
retroviral-mediated gene transfer have reached an 
advanced stage for non-malignant diseases like severe 
combined immunodeficiency (SCID), familial 
hypercholesterolaemia, haemophilia B, and for 
malignant diseases such as melanoma. 12 Gene 
therapy is currently undergoing evaluation and 
monitoring in developed nations. 12 
Currently, there has been a growing recognition of 
the influence of genetic factors in human disease. 2, 12, 
13 The appreciation of the importance of inherited 
components of common diseases, congenital 
malformations and cancer has increased substantially 
in recent years. In the last 10 yeas, revolutionary 
developments have occurred in the basic science of 
genetics. Major efforts have focused on the 
application of molecular genetics to understanding 
heritable and acquired diseases. 2, 12, 13 Extraordinary 
progress has been made to use these advances in the 
practice of medicine. 2, 6-12 It is well known that a 
collaborative international effort of unprecedented 
scope has been initiated, known as the Human 
Genome Project (HGP). 2 The spatial location of 
many human genes and DNA segments have been 
established. The rate of gene-disease associations has 
rapidly accelerated as consequences of 40, 000 
partially sequenced genes, and the genetic maps of 
humans provided in 1996. 14 At the beginning of this 
millennium the human genome had been virtually 
completely mapped, and cloning of human embryos is 
a scientific reality. 15 Researchers can now identify 
and characterize new genes that are important in the 
pathogenesis of a vast number of inherited and 
acquired human disorders. The diagnostic, 
investigative and therapeutic potential of these efforts 
are reshaping entirely the way in which medicine is 
practiced, and research conducted in the new 
millennium. 14, 15 
Regrettably, despite the tremendous progress 
made is medical genetics; the field seems to be the 
most neglected clinical discipline in our practice – 
particularly with regards to the availability of the most 
basic laboratory investigatory facility. Karyotyping – 
which was first developed in the 1950’s1, 2 further 
refined in the 1970’s, 3 and had reached advanced 
technological perfection in the 1980’s5 and 1990’s2 is 
still rarely available to Nigerian children in whom the 
test is required for proper diagnosis, management and 
genetic counseling. 16 – 22 
There is a general agreement that one way to 
assess medical scientific progress in different 
countries is to analyse the publication rate in scientific 
journals23 and the nature of the limitations in facilities 
in such studies. The aim of this paper is to critically 
review the status of paediatric practice and research in 
Nigeria in the last one decade (1992 – 2001), with 
special reference to medical genetics. The paper aims 
at highlighting the importance of medical genetics in 
applied research in paediatrics in Nigeria, and 
drawing attention to the paucity of the investigatory 
facilities that could have improved the quality of 





The study consists of two series. In the first series, an 
audit of all publications in the last one-decade 
(between 1992 and 2001), of published studies in 8 
medical journals published in Nigeria was made.
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The total number of articles was recorded. The 
proportion of the contribution made by Nigerian 
pediatricians was noted from enumeration of articles 
devoted to paediatrics. Out of these, studies devoted 
to genetics and congenital malformations were noted, 
enumerated, and the contents critically analyzed, with 
a view to determining the limitations of the studies, 
particularly with regards to investigatory facilities. 
Also, disorders that were primarily non-genetic, but in 
which investigatory facilities based on cytogenetic 
analysis, special staining techniques, molecular 
testing, special biochemistry or electron microscopy 
could be useful, were enumerated, and the availability 
or paucity of the relevant investigations was noted. 
For studies in which all the relevant investigations 
were available, the role of collaboration with 
researchers abroad was noted. 
In the second series all articles published in the 
last 10 years (1992 – 2001) in two reputable 
international journals devoted to tropical paediatrics 
were enumerated, analyzed by topics, authors, and 
particular attention was paid to articles on genetics 
and congenital malformations, contributed by 
Nigerian authors. In such studies the availability or 
paucity of the relevant investigations as well as the 





The first series of published Nigerian studies revealed 
that of 2497 articles published in 8 Nigerian medical 
journals, 873 (35%) articles were devoted to 
paediatrics. Of these, 270 (31%) papers were related 
to genetics, dysmorphology and congenital 
malformations. There were also 101 (11.6%) of the 
873 articles that, were primarily on non-genetic 
disorders, but needing investigatory facilities based on 
cytogenetic analysis, special staining techniques, 
molecular testing, special biochemistry or election 
microscopy (Table 1). Thus, there were 371 (42.5%) 
of 873 studies devoted to paediatrics in which such 
special investigatory facilities could have improved 
the quality of practice or research in Nigeria. Only in 
8(2.2%) of 371 studies were the appropriate 
investigations available, mostly done either abroad or 
in collaboration with workers abroad. In the second 
series in two widely circulated international, quarterly 
journals on tropical paediatrics 1040 were articles 
were published in the last one decade; 281(27%) of 
these were contributed by Nigerian authors. Of these, 
35(12.5%) were devoted to genetics and congenital 
malformations on Nigerian children, but in only 7 of 
these were all the necessary investigations available, 
and they were done in developed nations (Table 1). 
 
Table 1: Audit over ten years (1992 – 2001) of Nigerian studies in paediatrics related to medical genetics 
 
First Series: Articles published in Nigeria 
 
No. of Nigerian medical journals reviewed 8 
Total no. of articles reviewed 2497 
No. of articles devoted to paediatrics 873 (35%) 
No. of papers related to genetic and various congenital malformations 270 (31% of 873) 
No. of non-genetic studies needing investigatory facilities based on cytogenetics, 
special staining techniques, electron microscopy  
101 (11.6% of 873) 
No. of studies in which appropriate investigations were available/done abroad or 
with collaboration abroad 
8 (2.2% of 371) 
 
Second series: Articles published abroad in tropical paediatric journals 
 
No. of foreign journals reviewed  2 
Total no. of articles reviewed 1040 
No. of articles contributed by Nigerian authors 281 (27%) 
No. of papers devoted to genetics and congenital malformations 35 (12.5% of 281) 
No. of Nigerian studies with adequate investigatory facilities (collaborative 
studies) 
7 (20% OF 35) 
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Table 2: Published Nigerian studies in paediatrics in which there was paucity of relevant investigation facilities 
related to medical genetics 
 
 Author(s) Centre Abbreviated title of paper Unavailable facilities 
 Asindi AA16 University of Calabar 
Teaching Hospital, 
Calabar 
Neurologic disabilities in 
children  
Karyotyping. 19 cases of Downs 
syndrome diagnosed on clinical 
grounds alone 







Karyotyping. Out of 531 major 
congenital malformations 14 were 
diagnosed as Down’s syndrome on 
clinical grounds alone 





Dental abnormalities in 
handicapped children 
Karyotyping. Cases of Down’s 
syndrome diagnosed on clinical 
grounds 






Bickers Adams syndrome 
Ultrasound or brain CT to 
demonstrate stenosis of aqueduct of 
Sylvius, Karyotyping 
 Folade et al28 University College 
Hospital, Ibadan 
Orbital rhabdomyosar – 
coma mimicking Burkitt’s 
lymphoma 
Immunohisto chemical stain, Electron 
microscopy. Histogenetic origin of 
tumor couldn’t be identified 





Infantile achalasia in  
Down syndrome 
 
 Karyotyping  
 Johnson & 
Mokuolu20 
University of Ilorin 
Teaching Hospital, 
Ilorin 
Russel-Silver syndrome  Karyotyping  
 
 
Table 3: Published Nigerian studies in paediatrics in which the relevant investigations related to medical 
genetics had to be done abroad 
 
 Author(s) Centre Abbreviated title of paper Unavailable facilities 





Kartagener’s syndrome  Nasal brushing techniques, 
photometric method, EM for 
demonstration of ciliary dyskinesia 





Hardings variant of 
Friedreich’s ataxia and 
type-1 NF  
Nerve growth factor assay; 
Mitochondrial malic acid emzyme, 
MRI 





Laurence – Moon- Bardet 
S– Biedl – syndrome  
Karyotyping. This is ideally 
indicated in any dysmorphic child 
 






pigmented naevus & early 
malignant transformation  
Tissue culture of cells of the 
neoplastic growth to carry out 
genetic biologic & immunologic 
characterization of tumour  





Screening for relevant metabolic 
genetic disorders 





Xeroderma pigmentosum  
(XP) 
XP Complementation grouping. 
DNA, studies and cell fusion 
techniques 









EM = Electron microscopy, NF = Neurofibromatosis, MRI = Magnetic resonance imaging 
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Table 4: Published Nigerian studies in paediatrics in which the relevant investigations related to medical genetic 





Centre Abbreviated title of 
paper 
Investigations done abroad 
 Eke & 
Simpson41 





Electron microscopy (EM) of 
stools, polyacrylamide gel 
electrophoresis (PAGE) of rotavirus 
done in Birmingham, UK 
 Omotade et 
al42 
Lagos University 




EM of stools, immunochemical 
staining, PAGE of rotavirus RNA, 
Rotavirus RNA genome done in 
Nottingham, UK 
 Adah & 
Olaleye43 
Lagos University 
Teaching Hosptal, Lagos 
Serotypes and 
genotypes of 
rotavirus strains in 
Nigeria 
ELISA,  radioactive dot-blot 
hybridisation technique, polymerase 
chain reaction (PCR) done in 
Germany 
 Ighogboja & 
Angyo44 




transferase defc. In 
a Nigerian infant 
Erythrocyte galactose-1-uridyl 
transferase activity assay done in a 
London hospital 
 
 Ahmed et 
al45 
Ahmadu Bello University 
Teaching Hospital, Zaria 
G6PD  and 
aflatoxins 
 
 Ahmed et 
al46 
Ahmadu Bello University 
Teaching Hospital, Zaria 
Aflatoxins & 
Neonatal jaundice 
Kit for UV quantitative method of 
G6PD assay obtained abroad. Also 
HPLC for quantifying aflatoxins 
levels in serum done in Liverpool, 
UK 
 
Same as above 
 







sickle cell disease 
Doppler US, hepatic angiography 
protein S levels, protein C levels, 
investigation of patient and family 
for inherited thrombophila done in 
Royal Free Hospital, London, UK 
G6PD = Glucose-6-phosphate dehydrogenase; HPLC = High performance liquid chromatography, US = Ultra 
sound, UV = Ultra violet, 
defc. = deficiency 
 
 
Table 2 gives a summary of examples of published 
Nigerian studies in paediatrics in which there was 
paucity of relevant investigations related to medical 
genetics. This table summarises 7 articles based on 
experience of paediatric colleagues elsewhere in 
Nigeria. The facilities not available are indicated in 
the table. Table 3 also gives examples from 8 
published Nigerian studies in paediatrics in which 
there was paucity of relevant investigations related to 
medical genetics. The facilities that were not available 
in Nigeria but which could have improved the quality 
of the work are indicated in tables 2 and 3. 
Table 4 gives a summary of some studies related 
to medical genetics or needing investigations based on 
molecular genetics contributed by Nigerian authors, in 
which investigatory facilities had to be obtained 





This audit reveals that Nigerian paediatricians have 
been very active in research, and have made 
significant contribution in reputable medical journals, 
locally and abroad. The papers published are of fairly 
high standard, but qualitative work on medical 
genetics is problematic and scientific progress in this 
very important and topical field is very slow, despite 
the fact that up to 30% of published studies, by 
Nigerian paediatricians, is related to genetics and
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This slow progress is attributable to paucity of the 
necessary, basic investigatory facilities. Thus, in 1986 
Asindi16 reviewed the neurologic disabilities in 
children in Calabar, and diagnosed 19 cases of Down 
syndrome on clinical grounds alone. No kayotyping 
was done because facilities were not available. 
Similarly, Adeyemo et al, 17 eight years later, (in 
1994) published their findings in a reputable 
international paediatric journal, on major congenital 
malformations in paediatric admissions, in UCH 
Ibadan, and claimed that out of 531 major congenital 
malformations 14 were diagnosed as Down syndrome, 
again on clinical grounds alone. 17 A year earlier (in 
1993) Olarenwaju and Renner18 in Lagos described in 
a female, the first case of infantile achalasia in 
Down’s syndrome. Unfortunately, facilities for 
karyotype study were not available. Six years after the 
report of Olarenwaju and Renner, 18 Oredugba and 
Sote19 (in 1999) in Lagos, analyzed the dental 
abnormalities in handicapped children and based their 
diagnosis of Down’s syndrome also on clinical 
grounds alone. No Karyotyping was available. Thus, 
for the last 13 years publications on Down syndrome 
in Nigerian children have been based on clinical 
features alone. 16-19 Although the diagnosis of Down 
syndrome (DS) can be made on clinical grounds, the 
differential diagnosis include a variety of disorders-
including other trisomies and triple X syndrome 
which share many features with DS.1, 2 
The chromosomal genetic defect in Down 
syndrome may be trisomy 21(in 95% of cases); 
various types of translocations ( 4%); the 
translocations include D/G translocations –t(14q21q), 
t(15q21q), t(13q21q) and G/G translocations 
consisting of t(21q21q) or t(22q21q); and mosaicism 
(46/47) (in 1%) 2,24. Overall, translocations account 
for 9% of the children with Down syndrome born to 
mothers below 35 years. 2 
It is very important to identify the type of genetic 
defect in Down syndrome since this is very useful for 
diagnosis and proper genetic counseling. 1,2,24 The 
genetic defect can be easily identified by karyotyping. 
The karyotype in Down syndrome determines the 
recurrence risk. Thus for trisomy 21 the overall 
recurrence risk is 1% while for translocations of the 
D/G type t(14q21q) the risk is 5% for maternal 
translocations and 2% for paternal, and the rare G/G 
translocations t(21q21q) carries a recurrence risk of 
100%. 1, 2 Therefore, without karyotyping, the 
diagnosis of Down syndrome can always be 
challenged and proper genetic counseling cannot be 
given. Unfortunately this basic genetic investigation is 
not readily available in Nigeria.  
Prenatal diagnosis of Down syndrome is now 
available using amniocentesis, chorionic villus 
sampling, alpha-fetoprotein, human chorionic 
gonadotrophine (HCG) and estriol. 24 Prenatal 
diagnosis improves the quality of genetic counseling 
and offers the couple the information needed to make 
decisions on available options. 1, 2, 24 
In 1993 Okogbo and Amadin reported a case of X-
linked hydrocephalus-Bickers-Adams syndrome in a 
child in Kano.25 The authors25 could not do trans-
fontanelle ultrasound or brain CT scan to demonstrate 
the stenosis of the aqueduct of Sylvius-the primary 
structural defect associated with the X-linked 
disorder. 26 An improvement in research on this 
condition in Nigeria was made in the work of Iroha 
and Egri-Okwaji27 who recently (in 2001) reported 
cases of Bickers-Adams syndrome in a Nigerian 
family based on the typical clinical presentation, 
genetic pedigree analysis and demonstration of the 
stenosis  of the aqueduct of Sylvius. 27 Johnson et al20 
recently described a case of Russel-Silver syndrome 
in a Nigerian child in Ilorin, and lamented that they 
could not perform karyotyping in the dysmorphic 
child. 
With regards to non-genetic disorders in which 
investigations related to cytogenetics are useful in 
arriving at the correct diagnosis, a recent examples is 
the work of Falade et al.28 These workers reported (in 
1998) a case of bilateral orbital rhabdomyosarcoma 
that was initially diagnosed as a case of Burkitts 
lymphoma. The authors highlighted the difficulties 
which because of lack of differentiation are associated 
with the diagnosis of small round cell tumours of 
childhood. 28  
Concerning examples of published Nigerian 
studies in paediatrics in which there was paucity of 
relevant investigatory facilities for medical genetics, 
from the personal experience of the author, eight 
selected studies are hereby discussed to illustrate the 
problem.21, 22, 29-34 
In 1997 Ahmed et al29 described a 4-year old male 
child with Kartagener’s syndrome (KS)-being the first 
case to be documented in Nigeria29 and followed up 
the case for 6 years. The diagnosis of KS depends on 
the combination of clinical features (mirror image 
dextrocardia –ie dextrocardia and situs inversus, 
associated with bronchiectasis and sinusitis, the so 
called Kartegener triad35) plus demonstration of 
abnormalities in the ultrastructure and function of the 
cilia. 29 With regards to the demonstration of ciliary 
dyskinesia and poor mucociliary clearance, only the 
saccharin test was available to Ahmed et al. 29 The 
saccharin test is a simple screening test of mucociliary 
clearance and involves the movement of particle of 
saccharin posteriorly through the nose. 35
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An abnormal test (as obtained in the patient described 
by Ahmed et al29) is usually highly suggestive of 
ciliary dyskinesia and would indicate a need for more 
sophisticated studies such as nasal brushing technique 
and examination by photometric method35 for ciliary 
motility and electron microscopy to examine for a 
variety of structural defects. Unfortunately, in 
Nigeria, such tests are still not available, although 
they have been well established in clinical practice for 
more than 20years. 36 Thus, Rutland and Cole, 36 in 
1980, described non-invasive sampling of nasal cilia 
for measurement of beat frequency and study of 
ultrastructure in a variety of respiratory disorders. 
In 1999 Ahmed and Falope30 described an unusual 
association of a rare variant of Friedreich’s ataxia 
with type-1 neurofibromatosis (NF1) in a Nigerian 
Fulani family (in a 39-year old mother and her 12-
year old) and followed up the cases for 5 years. The 
authors concluded that they were dealing with a 
combination of Harding’s spastic ataxia of 
childhood37 and NF1, which formed an interesting but 
puzzling phenomenon. 30 Cranial and spinal 
computerized tomography (CT) scans in both mother 
and child showed no signs of tumours. 30 The authors 
wished they could do magnetic resonance imaging 
(MRI) on the patients, since CT scan is not as good as 
magnetic resonance at demonstrating posterior fosssa 
abnormalities, spinal tumours and spinocerebellar 
degenerative processes, 38 but this was not possible 
then due to lack of facilities.  Karyotyping, DNA 
probe on chromosome 17, assay of nerve growth 
factor and the levels of mitochondrial malic acid 
enzymes might have contributed to better 
understanding of the complex association. 30 
Ahmed and Hassan21 described Laurence-Moon-
Bardet-Biedl syndrome (LMBBS) in siblings of a 
Nigerian family in 1999-the first of such description 
in Nigeria. 21 LMBBS is an autosomal recessive 
disorder characterized by the pentad of obesity, 
mental retardation, digital anomalies (postaxial 
polydactyly, syndactyly or both), retinal dystrophy 
(retinitis pigmentosa) and hypogonadism. 39 Brain CT 
scan, which was indicated in the proband because of 
the associated ataxic gait, was normal. Karyotyping 
could not be done. Although the karyotype in LMBBS 
is normal and doesn’t assist in the diagnosis of 
LMBBS, 39 it could have been informative to do it, 
since karyotyping is indicated in any child with 
dysmorphic features, 24  
Again, Ahmed31 in 1999 described his experience 
of childhood ataxic syndromes in Sokoto. 31 The 
author noted that metabolic genetic disorders did not 
seem to play a significant role in his series. Facilities 
for screening for the relevant metabolic genetic 
disorders were not available.  
In 2001 Ahmed et al32 described the first series on 
xeroderma pigmentosum syndrome in black children 
in the West African sub region and noted the 
phenotypic variations among the three consecutive 
siblings of a Nigerian family. We confessed that we 
had no facilities in Nigeria to determine the 
complementation groups of our patients and the 
individual gene mutations of these children. 32 
Furthermore, in 2001 Ahmed33 and Ahmed et al22 
described their experience of neurocutaneous 
syndromes in Nigerian children33 and of pathological 
obesity syndromes in Nigerian children, 22 with 
special emphasis on practical management problems. 
22, 33 In these studies22, 33 the limitation in diagnostic 
facilities particularly chromosomal studies, were some 
of the major practical management problems.  
With regards to non-genetic disorders in which 
cytogenetic and molecular genetic investigations are 
needed, Ahmed et al34 in 2001 described a case of 
giant congenital pigmented naevus (GCPN) with 
unusual presentation and early malignant 
transformation in a Nigerian infant, 34 and concluded 
that the 6-month old infant had clinical and 
histological features of malignant melanoma, in 
association with the GCPN. Yet it has been shown 
that cells from neoplasms arising from GCPN, despite 
the clinical and histologic picture of malignant 
melanoma, could be phenotypically benign. 40 We 
lamented that we had no facilities to carryout genetic, 
biologic and immunologic characterization of the 
tumour to prove its malignant or benign nature. 34 
With regards to illustrative, published Nigerian 
studies in paediatrics, in which the relevant 
investigations related to medical genetics, molecular 
biology, special biochemistry or electron microscopy 
had to be done abroad, the following is a brief review 
of selected studies. 41 – 47. 
In 1991 Eke and Simpson 41 studied rota virus 
gastroentaritis at the University of Port-Harcourt 
Teaching Hospital (UPHTH). Stool samples had to be 
sent by courier mail to Birmingham, England for rota 
virus page typing using polyacrylamide gel 
electrophoresis, and electron microscopy. Sera were 
also posted to England for ELISA.41 
In 1995 Omotade et al 42 looked into rota virus 
serotypes and genotypes in children with diarrhoea in 
Lagos. The electron microscopy of stools, 
immunochemical staining, polyacryl gel 
electrophoresis (PAGE) of rotavirus RNA genome 
were done abroad. 42 Similarly, Adah and Olaleye43 
studied the serotypes and genotypes of rota virus 
strains also in Lagos and the ELISA, radioactive dot-
blot hybridization technique and polymerase chain 
reaction (PCR) were all done in Germany. In 1995 
Ighogboja and Angy in Jos described a child with
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galactose-1-phosphate uridyl transferase deficiency 
and the assay of the enzyme had to be done abroad (in 
a London hospital).  44 The authors suggested that 
there is no doubt that cases of galactosaemia in our 
community remain largely undiagnosed; and that 
there is the need to establish regional centers for 
metabolic screening in our country. 44  
In 1995 Ahmed et al 45 looked into glucose-6-
phosphate dehydrogenase (G6PD) status of neonates 
in Zaria with special reference to aflatoxins. The kit 
for UV quantitative method of G6PD assay had to be 
obtained from Liverpool, UK. Also, the high 
performance liquid chromatography (HPLC) for 
quantifying the aflatoxin levels in serum had to be 
done abroad. 45, 46 
In 1997 Ahmed et al47 described a child with 
sickle cell anemia, oesophageal varices and recurrent 
haematemesis that turned out to be due to portal vein 
thrombosis. Portal vein thrombosis is exceedingly rare 
in sickle cell anemia. Doppler ultrasonography and 
hepatic angiography done in Royal Free Hospital, 
London (RFH) confirmed the portal vein thrombosis. 
The child was also investigated at RFH for inherited 
thrombophilia, and these investigations showed that 
the child might have a genetic predispositon to 
prothrombotic tendency. 47 
It is obvious that our experience 21, 22, 29 – 33 is 
similar to the experience of our paediatric colleagues 
elsewhere in Nigeria, 16 – 20 with regards to paucity of 
special investigatory facilities for medical genetics. It 
has been recognized that as a group, genetic disorders 
represent a sizeable problem in developed countries, 
where environmental causes of ill health have become 
far less important due to improved nutrition, living 
standards and better medical care. 13 It has also been 
recognized that, currently, environmental problems 
(e.g. diarrhoea, malnutrition and infections,) in 
developing nations greatly overshadow those of 
genetic origin. 13 There is a general agreement, 
however, that as funding and facilities improve, and 
environmental causes of ill health are controlled, 
genetic disorders will become increasingly important 
in the developing world, as they have been in the 
developed nations. 13 Furthermore, our present audit 
has demonstrated, to some extent, that progress in 
applied research in paediatrics is enhanced by 
application of molecular genetics even in a common 
tropical paediatric problem such as diarrhea, 41 - 43 
which is regarded as primarily environmental and 
acquired disorder. Similarly, we have also given 
examples of environmental, non-genetic disorders 
such as tumours 28, 34 which may need investigatory 
facilities based on cytogenetics, molecular genetics, 
special biochemistry, special staining techniques, cell 
cultures or electron microscopy for proper diagnosis 
and for improvement of quality of care and research 
even in a developing nation, like Nigeria. 28, 34. 
A recent Spanish study 23 that surveyed journals 
listed by the Science Citation Index of  160 nations 
for the period from 1991 until 1998 has shown that 
85% of all scientific papers during this period, 
originated from three regions: Western Europe, North 
America and Asia (Japan, Hong Kong, Indonesia, 
Malaysia, China Singapore, South Korea, Taiwan and 
Vietnam in that order). Up to 70% were attributable to 
just Western Europe and North America. In contrast 
the African continent as a whole produced only 1% of 
worldwide scientific publications during this period. 
The study also showed that papers from Latin 
America, Eastern Europe and the Middle East had a 
foreign co-author on at least 50% of the publications. 
The authors 23 suggested that in developing world 
collaboration with developed nations provides a 
strategy to address these disparities; and that for small 
economies; this collaboration with developed nations 
may be the best approach to increased scientific 
progress. 23  
Examples of this type of collaboration at the 
individual researcher level in Nigeria have been 
discussed in this review. 44 – 47 Nigerian paediatricians 
continue to maintain such collaboration as evidenced 
by more recent publications. 48 For example, in 2002, 
Ikpatt et al48 in their study of seroprevalence of human 
herpes virus–8 (HHV-8) among children in Calabar, 
South-eastern Nigeria collaborated with the Oncology 
Unit of the University of Padua, Italy where sera were 
screened for antibodies for the small capsid related 
protein encorded by ORF65 using ELISA technique, 
with purified recombinant dehydrofolate reductase 
(DHFR) as control antigen48. Although such 
collaboration, at the individual levels, 41 – 48 is 
commendable and can enhance progress in research in 
our country, it will not address our research needs to 
an appreciable extent. It seems that collaboration at a 
higher level - at governmental level is also urgently 
needed. 
The establishment of a medical genetics research 
and referral centre for the country is urgently needed. 
Such a centre can be set up in collaboration with 
international scientific organizations on terms that are 
most acceptable and beneficial to Nigerians The 
centre should have facilities for basic genetic 
investigations such as cell culture, karyotyping, other 
cytogenetic analysis, molecular testing, special 
staining techniques for modern immunodiagnostic and 
immunopathological tests, screening for metabolic 
disorders, polymerase chain reaction (PCR) – based 
investigations for diagnosis of a variety of infections, 
and special biochemistry.  
The establishment of this centre will curtail the
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costly and cumbersome practice of posting specimen 
(stool, urine, blood, other body fluids, and tissues) 
abroad by individual Nigerian researchers41 – 48 and 
will minimize the costly, often risky, referral of 
patients abroad.49 The centre will also enhance 
progress in applied research in paediatrics and other 
medical and surgical specialties, and will improve the 
quality of health care in the country. This is because 
the centre will be relevant not only to the patients with 
genetic disorders, congenital malformations and 
tumours, but also to those with the common non-
genetic problems such as malaria50 – 52 and 
tuberculosis. 53. Thus, recent molecular genetic studies 
on HLA genes and malaria have shown that the 
possession of HLA-B-53 allele in Gambian children 
reduces the risk of death from severe malaria by up to 
40%50. It has also been demonstrated that natural 
immunity to malaria may be conferred by complex 
genetic factors governing nitric oxide synthase 
activity. 51 Furthermore, remarkable progress has been 
made in the production of safe and effective malaria 
vaccines based on recombinant DNA technology. 52 
Therefore, modern research on malaria needs the 
application of molecular genetics. With regards to 
tuberculosis, various polymerase chain reaction (PCR) 
assays have been developed for faster identification of 
mycobacteria. 53 The value of such investigations in 
routine laboratory work was first assessed more than a 
decade ago (in 1991), and it was concluded that DNA 
amplification is a reliable method for early detection 
of mycobacterial infections. 53 Again, this shows that 
progress in the field of tuberculosis can be enhanced 
by application of molecular biology. 
I do not recommend the establishment of costly, 
sophisticated genetic laboratories for every teaching 
hospital. This is not feasible, not affordable and is 
inappropriate49 for a developing nation like Nigeria. It 
is obvious that at least one medical genetics research 
and referral centre is needed for a country of more 
than one hundred million people. 
Sawyer54 has identified four principal kinds of 
organizations, which may support medical education, 
research and care in developing countries. These are 
philanthropic foundations, governmental agencies, 
non-governmental organizations - such as 
professional scientific and technical societies, and 
industrial concerns. Various nations provide support 
to developing countries through governmental 
agencies. Sawyer54 observes that there is likely to be 
considerable bureaucracy in the pursuit and use of 
such funds, but they may be the most likely source of 
support for big projects54 (like the proposed medical 
genetics research centre). 
A plea is, therefore made to the Federal 
Government of Nigeria to urgently set up the 
machinery for the establishment of a Medical 
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